Category: Psoriasis
Global Psoriasis
-
Global Systemic Psoriasis Therapeutics Market 2024-2028
... period. The report on the systemic psoriasis therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an ... Read More
-
Generalized Pustular Psoriasis (GPP) - Global Clinical Trials Review, 2024
... scenario. This report provides top line data relating to the clinical trials on Generalized Pustular Psoriasis (GPP). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. ... Read More
-
Plaque Psoriasis (Psoriasis Vulgaris) - Global Clinical Trials Review, 2024
... scenario. This report provides top line data relating to the clinical trials on Plaque Psoriasis (Psoriasis Vulgaris). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. ... Read More
-
2024 Global: Photodynamic Therapy Market - Innovative Markets Forecast (2030) report
... 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 using regression ... Read More
-
Autoimmune Drugs Market Size, Trends, Analysis, and Outlook By Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Psoriasis, Inflammatory Bowel Disease, Others), By Distribution Channel (Hospital, Pharmacy, Drug Store/Retail Pharmacy, Online), by Region, Country, Segment, and Companies, 2024-2030
... The global Autoimmune Drugs market size is poised to register 6.93% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Autoimmune Drugs ... Read More
-
Anti-inflammatory Therapeutics Market Size, Trends, Analysis, and Outlook By Drug Class (Nonsteroidal Anti-inflammatory Diseases (NSAIDs), Corticosteroids, Biologics), By Indication (Arthritis, Respiratory Disease, Multiple Sclerosis, Psoriasis, Anti-inflammatory Bowel Disease (IBD), Others), by Region, Country, Segment, and Companies, 2024-2030
... Companies, 2024-2030 The global Anti-inflammatory Therapeutics market size is poised to register 6.24% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global ... Read More
-
The 2025-2030 World Outlook for Interleukin Blockers for Psoriasis Treatments
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2025-2030 World Outlook for Psoriasis Medicines
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Psoriatic Arthritis Treatments
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Psoriasis Treatments
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Psoriasis Drugs
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Systemic Psoriasis Biologics
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Tumor Necrosis Factor Inhibitors for Psoriasis Drugs
... estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. ... Read More
-
The 2025-2030 World Outlook for Systemic Psoriasis Therapeutics
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
Psoriatic Arthritis Treatment Global Market Report 2024
... Retail Pharmacies; Online PharmaciesCovering: AbbVie Inc.; Amgen Astellas BioPharma K.K.; Johnson & Johnson Services Inc.; Bristol-Myers Squibb Company; Celgene Corporation Psoriatic Arthritis Treatment Global Market Report 2024 from The Business Research Company provides strategists, marketers ... Read More
-
Photodynamic Therapy Devices Market Size - By Product (Diode Lasers, Disposable Fiber Optic Light Delivery Devices), Application (Cancer, Actinic Keratosis, Acne, Psoriasis), End-use (Hospitals, Dermatology Clinics) & Global Forecast, 2024 - 2032
... Devices Market will grow at an 8.3% CAGR from 2024 to 2032, fueled by the growing prevalence of actinic keratosis coupled with rapid technological advancements. Actinic keratosis cases are on the rise due to factors ... Read More
-
Skincare Devices Market by Product (Diagnostic Devices, Treatment Devices), Application (Acne, Psoriasis, and Tattoo Removal, Body Contouring and Fat Removal, Cellulite Reduction), End-Use - Global Forecast 2024-2030
... USD 13.93 billion in 2023 and expected to reach USD 15.02 billion in 2024, at a CAGR 9.81% to reach USD 26.83 billion by 2030. Global Skincare Devices Market FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Tofacitinib Global Market Opportunities And Strategies To 2032 Including: 1) By Drug Class: Antirheumatic; Janus kinase inhibitor; Immunosuppressant 2) By Dosage Strength: 5mg; 10mg; 11mg; 22mg 3) By Indication: Ulcerative Colitis; Rheumatoid Arthritis; Psoriasis 4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy Covering: Pfizer Inc.; Beacon Pharmaceuticals PLC; Pharmascience Inc.; Qilu Pharmaceutical Co., Ltd; Delta Pharma Limited
... Pharmacy; Retail Pharmacy; Online PharmacyCovering: Pfizer Inc.; Beacon Pharmaceuticals PLC; Pharmascience Inc.; Qilu Pharmaceutical Co., Ltd; Delta Pharma Limited Tofacitinib Global Market Opportunities And Strategies To 2032 from The Business Research Company provides the strategists; ... Read More
-
Psoriatic Arthritis Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... reach US$ 15.9 Billion by 2028, exhibiting a growth rate (CAGR) of 10.57% during 2022-2028. Psoriatic arthritis is an autoimmune disorder wherein the immune system attacks the joints and causes inflammation. Its treatment options vary ... Read More
-
Global Plaque Psoriasis Treatment Market - 2023-2030
... the forecast period 2023-2030. Plaque psoriasis also known as psoriasis vulgaris is a long-lasting and chronic autoimmune skin disease that causes cells to reproduce very quickly. It’s the most common type of psoriasis that causes ... Read More
-
Dermatological Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented by Application (Alopecia, Herpes, Psoriasis, Rosacea, Atopic Dermatitis, and Other Applications), by Drug Class (Anti-infectives, Corticosteroids, Anti-acne, Calcineurin Inhibitors, Retinoids, and Other Drug Classes), and By Region, Competition
... with an expected Compound Annual Growth Rate (CAGR) of 7.98% through 2028. This market is undergoing significant expansion and innovation, fundamentally reshaping the landscape of healthcare technology. Disposable medical sensors have emerged as critical components ... Read More
-
Remicade Biosimilar Global Market Report 2023 Including: 1) By Type: 100mg/10ml; 500mg/50ml 2) By Disease Indication: Ulcerative Colitis; Rheumatoid Arthritis; Ankylosing Spondylitis; Crohn’s Disease; Psoriatic Arthritis; Plaque Psoriasis 3) By Application: Blood Disorders; Oncology Diseases Covering: AbbVie Inc.; Novartis AG; Amgen Inc; Viatris Inc.; Teva Pharmaceutical Industries Ltd.
... Novartis AG; Amgen Inc; Viatris Inc.; Teva Pharmaceutical Industries Ltd. Remicade Biosimilar Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess ... Read More
-
Chronic Plaque Psoriasis Therapeutics Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type
... 2022 and its CAGR from 2018 to 2022, and also forecasts its market size to the end of 2028 and its CAGR from 2023 to 2028. For geography segment, regional supply, demand, major players, price ... Read More
-
Dermatology Drugs Market Covering Acne; Dermatitis; Psoriasis; Alopecia; Global Summary 2023
... of per capita consumption, the market was $7.1 and in terms of global GDP, the market was 0.05%. Dermatology drugs was the tenth largest segment within the market accounting for 3.4% preceded and followed by ... Read More
-
Global Immunology Market Size study & Forecast, by Drug Class (Monoclonal Antibody, Immunosuppressants, Fusion Proteins, Others) by Disease Indication (Rheumatoid Arthritis, Psoriatic Arthritis, Plaque Psoriasis, Ankylosing Spondylitis, Inflammatory Bowel Disease, Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Regional Analysis, 2022-2029
... Pharmacies, Retail Pharmacies, Online Pharmacies) and Regional Analysis, 2022-2029 Global Immunology Market is valued at approximately USD 97.93 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 8.5% ... Read More
Research Assistance
